Biostem Technologies Inc
OTC:BSEM

Watchlist Manager
Biostem Technologies Inc Logo
Biostem Technologies Inc
OTC:BSEM
Watchlist
Price: 23.36 USD -6.49%
Market Cap: 381.8m USD
Have any thoughts about
Biostem Technologies Inc?
Write Note

Wall Street
Price Targets

BSEM Price Targets Summary
Biostem Technologies Inc

Wall Street analysts forecast BSEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BSEM is 24.74 USD with a low forecast of 24.49 USD and a high forecast of 25.46 USD.

Lowest
Price Target
24.49 USD
5% Upside
Average
Price Target
24.74 USD
6% Upside
Highest
Price Target
25.46 USD
9% Upside
Biostem Technologies Inc Competitors:
Price Targets
UCB
Ucb SA
6% Downside
AETHER
Aether Industries Ltd
36% Upside
300725
PharmaBlock Sciences Nanjing Inc
8% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
36% Upside
4516
Nippon Shinyaku Co Ltd
4% Downside
STAR
Strides Pharma Science Ltd
31% Upside
HITI
High Tide Inc
67% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Biostem Technologies Inc

For the last 12 years the compound annual growth rate for Biostem Technologies Inc's revenue is 23%. The projected CAGR for the next 2 years is 348%.

23%
Past Growth
348%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biostem Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biostem Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BSEM's stock price target?
Price Target
24.74 USD

According to Wall Street analysts, the average 1-year price target for BSEM is 24.74 USD with a low forecast of 24.49 USD and a high forecast of 25.46 USD.

What is Biostem Technologies Inc's Revenue forecast?
Projected CAGR
348%

For the last 12 years the compound annual growth rate for Biostem Technologies Inc's revenue is 23%. The projected CAGR for the next 2 years is 348%.

Back to Top